Ledipasvir / Sofosbuvir -- Benefit Assessment According to §35a Social Code Book V [Internet].

The aim of this report was to assess the added benefit of the fixed-dose combination of ledipasvir / sofosbuvir compared with the appropriate comparator therapy (ACT) in adult patients with chronic hepatitis C (CHC).

http://ift.tt/2rz519w